β-blockers Protect Against Dispersion of Repolarization During Exercise in Congenital Long-QT Syndrome Type 1
Overview
Physiology
Authors
Affiliations
Introduction: β-Blocker therapy reduces syncope and sudden death in long-QT syndrome type 1 (LQT1), but the mechanism of protection is incompletely understood. This study tested the hypothesis that β-blockade reduces QT prolongation and dispersion of repolarization, measured as the T peak-to-end interval (T(pe) ), during exercise and recovery in LQT1 patients.
Methods And Results: QT and T(pe) were measured in 10 LQT1 patients (33 ± 13 years) and 35 normal subjects (32 ± 12 years) during exercise tests on and off β-blockade. In LQT1 patients, β-blockade reduced QT (391 ± 25 milliseconds vs 375 ± 26 milliseconds, P = 0.04 during exercise; 419 ± 41 milliseconds vs 391 ± 39 milliseconds, P = 0.02 during recovery) and markedly reduced T(pe) (91 ± 26 milliseconds vs 67 ± 19 milliseconds, P = 0.03 during exercise; 103 ± 26 milliseconds vs 78 ± 11 milliseconds, P = 0.02 during recovery). In contrast, in normal subjects, β-blockade had no effect on QT (320 ± 17 milliseconds vs 317 ± 16 milliseconds, P = 0.29 during exercise; 317 ± 13 milliseconds vs 315 ± 14 milliseconds, P = 0.15 during recovery) and mildly reduced T(pe) (69 ± 13 milliseconds vs 61 ± 11 milliseconds, P = 0.01 during exercise; 77 ± 19 milliseconds vs. 68 ± 14 milliseconds, P < 0.001 during recovery).
Conclusion: In LQT1 patients, β-blockers reduced QT and T(pe) during exercise and recovery, supporting the theory that β-blocker therapy protects LQT1 patients by reducing dispersion of repolarization during exercise and recovery.
McCormick L, Wadmore K, Milburn A, Gupta N, Morris R, Held M J Physiol. 2023; 601(17):3739-3764.
PMID: 37428651 PMC: 10952621. DOI: 10.1113/JP284994.
Pharmacological rescue of specific long QT variants of KCNQ1/KCNE1 channels.
Zou X, Wu X, Sampson K, Colecraft H, Larsson H, Kass R Front Physiol. 2022; 13:902224.
PMID: 36505078 PMC: 9726718. DOI: 10.3389/fphys.2022.902224.
Exercise Test for Patients with Long QT Syndrome.
Chan C, Hu Y, Chen P, Wu I, Chen S Acta Cardiol Sin. 2022; 38(2):124-133.
PMID: 35273433 PMC: 8888329. DOI: 10.6515/ACS.202203_38(2).20211101A.
Went T, Sultan W, Sapkota A, Khurshid H, Qureshi I, Jahan N Cureus. 2021; 13(9):e17632.
PMID: 34646680 PMC: 8485362. DOI: 10.7759/cureus.17632.
Li Z, Ridder B, Han X, Wu W, Sheng J, Tran P Clin Pharmacol Ther. 2018; 105(2):466-475.
PMID: 30151907 PMC: 6492074. DOI: 10.1002/cpt.1184.